Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A G Sandercock

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2015
Does personalized medicine exist and can you test it in a clinical trial?Peter A G Sandercock
Stroke|June 25, 2015
Short History of Confidence Intervals: Or, Don't Ask "Does the Treatment Work?" but "How Sure Are You That It Works?"Peter A G Sandercock
The Lancet. Neurology|June 13, 2015
A call to revolutionise acute stroke care and researchPeter A G Sandercock
Current Neurology and Neuroscience Reports|July 2, 2017
Controversies in ThrombolysisPeter A G Sandercock, Stefano Ricci
The New England Journal of Medicine|April 12, 2002
Warfarin or aspirin for recurrent ischemic strokeStephanie C Lewis, Peter A G Sandercock
Trials|April 23, 2011
The International Stroke Trial databasePeter A G Sandercock, Maciej Niewada, Anna Członkowska, et al.
BMJ (Clinical Research Ed.)|November 27, 2012
Improving the process of translational researchH Bart van der Worp, Peter A G Sandercock
The Cochrane Database of Systematic Reviews|July 23, 2008
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic strokePeter A G Sandercock, Carl Counsell, Mei-Chiun Tseng
The Cochrane Database of Systematic Reviews|October 10, 2008
Anticoagulants for acute ischaemic strokePeter A G Sandercock, Carl Counsell, Ayeesha K Kamal
The Cochrane Database of Systematic Reviews|April 17, 2009
Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attackPeter A G Sandercock, Lorna M Gibson, Ming Liu
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2015
Does personalized medicine exist and can you test it in a clinical trial?Peter A G Sandercock
Stroke|June 25, 2015
Short History of Confidence Intervals: Or, Don't Ask "Does the Treatment Work?" but "How Sure Are You That It Works?"Peter A G Sandercock
The Lancet. Neurology|June 13, 2015
A call to revolutionise acute stroke care and researchPeter A G Sandercock
Current Neurology and Neuroscience Reports|July 2, 2017
Controversies in ThrombolysisPeter A G Sandercock, Stefano Ricci
The New England Journal of Medicine|April 12, 2002
Warfarin or aspirin for recurrent ischemic strokeStephanie C Lewis, Peter A G Sandercock
Trials|April 23, 2011
The International Stroke Trial databasePeter A G Sandercock, Maciej Niewada, Anna Członkowska, et al.
BMJ (Clinical Research Ed.)|November 27, 2012
Improving the process of translational researchH Bart van der Worp, Peter A G Sandercock
The Cochrane Database of Systematic Reviews|July 23, 2008
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic strokePeter A G Sandercock, Carl Counsell, Mei-Chiun Tseng
The Cochrane Database of Systematic Reviews|October 10, 2008
Anticoagulants for acute ischaemic strokePeter A G Sandercock, Carl Counsell, Ayeesha K Kamal
The Cochrane Database of Systematic Reviews|April 17, 2009
Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attackPeter A G Sandercock, Lorna M Gibson, Ming Liu
Pageof 7